CSIMarket
 


United Therapeutics Corporation  (UTHR)
Other Ticker:  
 

United Therapeutics's Quick Ratio

UTHR's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




UTHR Quick Ratio (Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Current Liabilities Change 10.62 % 11.41 % -48.29 % -49.8 % -56.48 %
Y / Y Cash & cash equivalent Change 26.07 % 12.09 % 23.49 % 0.67 % -12.62 %
Quick Ratio MRQ 9.17 8.86 8.1 6.97 8.04
Overall Ranking # # # # #
Seq. Current Liabilities Change 9.88 % -13.77 % -0.09 % 16.86 % 10.67 %
Seq. Cash & cash equivalent Change 13.64 % -5.65 % 16.1 % 1.27 % 1.05 %



Quick Ratio second quarter 2021 Comment
United Therapeutics's Cash & cash equivalent grew by 13.64 % in II. Quarter sequntially, faster than Current Liabilities, this led to improvement in United Therapeutics's Quick Ratio to 9.17, Quick Ratio remained below United Therapeutics Corporation average.

Within Major Pharmaceutical Preparations industry 139 other companies have achieved higher Quick Ratio than United Therapeutics in second quarter 2021. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are UTHR Segments?
See Quick Ratio UTHR on the trailing twelve month basis
Quick Ratio second quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 140
Healthcare Sector # 264
Overall Market # 587


Quick Ratio Statistics
High Average Low
9.17 4.06 0.86
(Jun 30 2021)   (Jun 30 2014)




Financial Statements
United Therapeutics's Current Liabilities $ 215 Millions Visit UTHR's Balance sheet
United Therapeutics's Cash & cash equivalent $ 1,968 Millions Visit UTHR's Balance sheet
Source of UTHR's Sales Visit UTHR's Sales by Geography




Companies with similar Quick Ratio in the quarter endingJun 30 2021, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2021 MRQ Cash & cash equivalentJun 30 2021 MRQ Current Liabilities
Cormedix Inc   25.05 $ 78.252  Millions$ 3.123  Millions
Werewolf Therapeutics Inc   24.86 $ 183.233  Millions$ 7.370  Millions
Applied Molecular Transport Inc   24.48 $ 199.520  Millions$ 8.149  Millions
Vera Therapeutics Inc   24.30 $ 91.625  Millions$ 3.771  Millions
Moleculin Biotech Inc   23.73 $ 79.506  Millions$ 3.350  Millions
Kempharm Inc  23.55 $ 132.295  Millions$ 5.617  Millions
Silverback Therapeutics Inc   23.13 $ 359.689  Millions$ 15.548  Millions
Point Biopharma Global Inc  22.98 $ 273.737  Millions$ 11.910  Millions
Gain Therapeutics inc  22.73 $ 43.163  Millions$ 1.899  Millions
Akouos inc   22.49 $ 271.751  Millions$ 12.081  Millions
Pliant Therapeutics Inc   22.32 $ 243.981  Millions$ 10.932  Millions
Praxis Precision Medicines Inc   22.28 $ 339.184  Millions$ 15.227  Millions
Bioxcel Therapeutics Inc   21.95 $ 273.057  Millions$ 12.441  Millions
Rhythm Pharmaceuticals inc   21.80 $ 368.154  Millions$ 16.889  Millions
Galecto Inc   21.41 $ 101.814  Millions$ 4.755  Millions
Actinium Pharmaceuticals Inc   21.16 $ 81.962  Millions$ 3.873  Millions
Rezolute Inc   20.86 $ 41.047  Millions$ 1.968  Millions
Tonix Pharmaceuticals Holding Corp   20.51 $ 165.745  Millions$ 8.081  Millions
Mustang Bio inc   20.42 $ 129.923  Millions$ 6.361  Millions
Prometheus Biosciences Inc   20.34 $ 304.389  Millions$ 14.963  Millions
Inozyme Pharma Inc   19.72 $ 137.464  Millions$ 6.972  Millions
Pds Biotechnology Corp  19.44 $ 74.749  Millions$ 3.845  Millions
Trillium Therapeutics Inc   19.32 $ 264.537  Millions$ 13.690  Millions
Merrimack Pharmaceuticals Inc  19.31 $ 14.909  Millions$ 0.772  Millions
Agios Pharmaceuticals Inc   19.05 $ 969.124  Millions$ 50.878  Millions
Anaptysbio inc  18.96 $ 390.851  Millions$ 20.616  Millions
Neubase Therapeutics inc   18.82 $ 59.096  Millions$ 3.140  Millions
Ovid Therapeutics Inc   18.81 $ 212.344  Millions$ 11.290  Millions
Magenta Therapeutics Inc   18.75 $ 207.805  Millions$ 11.083  Millions
Neximmune Inc   18.75 $ 102.796  Millions$ 5.483  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PDEX's Profile

Stock Price

PDEX's Financials

Business Description

Fundamentals

Charts & Quotes

PDEX's News

Suppliers

PDEX's Competitors

Customers & Markets

Economic Indicators

PDEX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright Š 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071